PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer.

MLA

van den Heerik, Anne Sophie V. M., et al. “PORTEC-4a: International Randomized Trial of Molecular Profile-Based Adjuvant Treatment for Women with High-Intermediate Risk Endometrial Cancer.” International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society, vol. 30, no. 12, Dec. 2020, pp. 2002–07. EBSCOhost, https://doi.org/10.1136/ijgc-2020-001929.

APA

van den Heerik, A. S. V. M., Horeweg, N., Nout, R. A., Lutgens, L. C. H. W., van der Steen-Banasik, E. M., Westerveld, G. H., van den Berg, H. A., Slot, A., Koppe, F. L. A., Kommoss, S., Mens, J. W. M., Nowee, M. E., Bijmolt, S., Cibula, D., Stam, T. C., Jurgenliemk-Schulz, I. M., Snyers, A., Hamann, M., Zwanenburg, A. G., … Creutzberg, C. L. (2020). PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society, 30(12), 2002–2007. https://doi.org/10.1136/ijgc-2020-001929

Chicago

van den Heerik, Anne Sophie V M, Nanda Horeweg, Remi A Nout, Ludy C H W Lutgens, Elzbieta M van der Steen-Banasik, G Henrike Westerveld, Hetty A van den Berg, et al. 2020. “PORTEC-4a: International Randomized Trial of Molecular Profile-Based Adjuvant Treatment for Women with High-Intermediate Risk Endometrial Cancer.” International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society 30 (12): 2002–7. doi:10.1136/ijgc-2020-001929.